|
|
|
| Clinical Efficacy and Safety of Camrelizumab Combined with Lenvatinib in First-line Treatment of Advanced HCC |
| TANG Lei, ZUO Hongbo, LIU Qiulian, LI Yanbing, XIA Yun, WANG Zhi, SHI Xin |
| First-author's address: Second Department of Cancer, Jiujiang NO.1 People's Hospital, Jiujiang 332000, China |
|
|
|
|
|
|
Received: 08 November 2023
|
|
|
|
|
|
|
